NEW YORK (GenomeWeb News) — CollabRx and CellNetix Pathology & Laboratories have signed a multi-year agreement that lets CellNetix make use of CollabRx's technology and content resources in providing sequencing-based testing for oncology.
Registering provides access to this and other free content.
Already have an account?Login Now.
Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.
In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.
Scripps Research Institute investigators peer back at the RNA world.
In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.